Agenus Inc.
Clinical trials sponsored by Agenus Inc., explained in plain language.
-
Desperate cancer patients get early access to promising drug combo
Disease control AVAILABLEThis program offers early access to a combination of two immunotherapy drugs, botensilimab and balstilimab, for people with serious or life-threatening cancers like colorectal, pancreatic, lung, liver, melanoma, sarcoma, ovarian, or prostate cancer. It is for patients who have tr…
Sponsor: Agenus Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Cancer patients who responded to experimental immunotherapy can now continue treatment
Disease control AVAILABLEThis expanded access program offers balstilimab, alone or with zalifrelimab, to cancer patients who previously received these drugs in a clinical trial and saw benefit. The goal is to allow continued treatment for those who wish to stay on therapy. Only patients who completed the…
Sponsor: Agenus Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC